chemotherapy response
Showing 1 - 25 of >10,000
Breast Cancer Trial in Dallas (Digital Mammography, Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml)
Active, not recruiting
- Breast Cancer
- Digital Mammography
- Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
-
Dallas, TexasUT Southwestern Medical Center
Jan 2, 2023
Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical
Completed
- Sarcoma
-
Irvine, CaliforniaBeckman Laser Institute
Oct 28, 2022
DLCS for Predicting Neoadjuvant Chemotherapy Response
Recruiting
- Gastric Cancer
- +4 more
- develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 8, 2022
Breast Cancer Trial in Boston (Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort, Diffuse Optical
Enrolling by invitation
- Breast Cancer
- Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
- Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
-
Boston, MassachusettsBoston Medical Center
Sep 20, 2022
Using Diffuse Optical Spectroscopic Imaging
Withdrawn
- Breast Cancer
- Diffuse Optical Spectroscopy Imaging
-
Irvine, CaliforniaBeckman Laser Institute
Oct 28, 2022
Nomogram Predicting Survival in Chinese SCLC Patients
Completed
- Small Cell Lung Cancer
- initial chemotherapy response
- (no location specified)
Jan 8, 2023
Pancreatic Cancer, Ultrasonography, First-line Chemo Trial in Beijing (Contrast-enhanced ultrasound(CEUS))
Recruiting
- Pancreatic Cancer
- +2 more
- Contrast-enhanced ultrasound(CEUS)
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Feb 6, 2023
d to Predict Intra-arterial Chemotherapy Response in
Recruiting
- Retinoblastoma
- Dynamic contrast-enhanced MRI
-
Paris, FranceFondation A De Rothschild
Mar 18, 2022
r® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
Recruiting
- Gastric Cancer
-
Seoul, Korea, Republic ofNovomics
Oct 28, 2021
Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast
Recruiting
- Breast Cancer
- Response monitoring
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 24, 2023
Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)
Completed
- Recurrent Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Chemotherapy Response in Colorectal Cancer With/Without Liver
Recruiting
- Colorectal Cancer
- Colorectal Cancer Liver Metastasis
- surgical resection
- +2 more
-
Beijing, Beijing, China
- +3 more
Jul 16, 2022
t Pathologic Complete Response Observed in HER2 Positive Breast
Completed
- HER2+ Breast Cancer
-
Rawalpindi, Punjab, PakistanRawalpindi Medical University
Jun 26, 2023
Predicting Biomarker of Gastric Cancer Chemotherapy Response
Recruiting
- Gastric Cancer
- +2 more
-
Daegu, Korea, Republic ofKyungpook National University Medical Canter
Aug 8, 2021
Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))
Not yet recruiting
- Breast Cancer
- Arm I (No PMRT)
- Arm II (PMRT)
- (no location specified)
Aug 8, 2023
Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)
Not yet recruiting
- Inflammatory Breast Cancer
- Breast conserving surgery
- Radical modified mastectomy
- (no location specified)
Nov 14, 2023
Shear and Strain Elastography in Monitoring Response to NAC in
Not yet recruiting
- Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy Using SE and SWE
- shear wave and strain elastography
- (no location specified)
May 1, 2023
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
Breast Cancer Patients
Completed
- Neoadjuvant Chemotherapy
- Neoadjuvant therapy
-
Istanbul, TurkeyAcıbademAH
Nov 21, 2023
Head Neck Cancer Trial in Beijin (anti-PD-1 or PD-L1 antibody, postoperative radiaotherapy)
Recruiting
- Head and Neck Cancer
- anti-PD-1 or PD-L1 antibody
- postoperative radiaotherapy
-
Beijin, Beijing, ChinaNational Cancer Center /National Clinical Research Center for Ca
Mar 18, 2023
Checkpoint Inhibitors in Triple Negative Breast
Recruiting
- Triple Negative Breast Cancer
- Whole Genome Sequencing
- +7 more
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Jun 20, 2023
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
Neoadjuvant Chemotherapy Response in Invasive Breast Cancer
Not yet recruiting
- Breast Neoplasms
- shear wave elastography
- (no location specified)
Dec 19, 2021
Breast Cancer Trial in Gaia (Combined Aerobic and Resistance Exercise)
Not yet recruiting
- Breast Cancer
- Combined Aerobic and Resistance Exercise
-
Gaia, Porto, PortugalCentro Hospitalar Vila Nova Gaia e Espinho
Jul 27, 2023
Neo-adjuvant Chemotherapy Evluation in Gastric Cancer Patients
Recruiting
- Gastric Cancer
- Chemotherapy Effect
- Detection of levels of circulating EV-derived lncRNA-GC1
-
Beijing, Beijing, ChinaChinese PLA General Hospital Ethics Committee
Dec 12, 2022